PRA International, Inc. Names Phase Forward’s OutcomeLogix(TM) as Preferred Late Phase Solution

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that PRA International has named Phase Forward’s OutcomeLogix™ as its preferred late phase solution provider.

MORE ON THIS TOPIC